Latest news with #LSIUSA
Yahoo
05-05-2025
- Business
- Yahoo
The Lens Magazine Features Joe Kiani, Willow Laboratories Founder and Nutu Visionary, on Cover of Latest Issue Following LSI USA ‘25 Keynote
DANA POINT, Calif., May 05, 2025--(BUSINESS WIRE)--The Lens, LSI's executive-focused medtech magazine, proudly unveils Volume 2, Edition 3, featuring Joe Kiani, Founder and Executive Chairman of Willow Laboratories and visionary of the digital-health platform Nutu, as its cover story. Kiani, a trailblazing figure in health technology, shares exclusive insights into the future of patient monitoring, the evolution of medical device innovation and the critical role of patient safety initiatives globally. In the powerful discussion, Joe Kiani and the Audacity to Care: Reflections on Principle, Persistence, and Patient-Centered Innovation, Kiani shares the journey that began in a garage with a $40,000 loan and now shapes standards of care for hundreds of millions of patients worldwide. The profile charts his early pulse-oximetry breakthroughs at Masimo, his bold crusades against entrenched purchasing monopolies, and his latest mission to out-innovate diabetes through Willow Labs. He also opens up about founding the Patient Safety Movement Foundation and leading the charge toward eliminating preventable deaths in hospitals worldwide. "We have a real responsibility and an opportunity to change people's lives for the better," said Kiani. "And it's not easy. But it's everything." The in-depth feature also spotlights Nutu, Willow Labs' science-backed "nudge" platform that empowers people with pre-diabetes to reverse disease progression through personalized, data-driven coaching. Kiani also shares his vision for the future, where technology and compassion merge to save lives. "Sometimes the unintended consequences of what we do are greater than the consequences we planned. But if you keep your compass set on doing what's right for patients, good things can happen," Kiani adds. "Joe Kiani embodies the spirit of innovation and impact that The Lens seeks to celebrate," said Scott Pantel, CEO of LSI. "His unwavering commitment to advancing healthcare outcomes makes him one of the most influential voices in our industry today." The latest issue of The Lens is available for subscribers in print and digitally. To become a subscriber and access the full cover story, visit Marquee Keynote at LSI USA '25 Building on the cover collaboration, LSI was honored to host Joe Kiani to deliver the opening keynote address at LSI USA '25, March 17-21, 2025, at the Waldorf Astoria Monarch Beach Resort in Dana Point, California. Kiani's appearance opened a week that drew more than 1,600 executives, 450 emerging startup companies, 350 active investors from venture capital, private equity, family offices, accelerators, and angel groups, and key decision makers from multinational corporations including Medtronic, Boston Scientific, Intuitive and more. Kiani's remarks underscored the summit's 2025 theme of preventive and personalized care. "Landing Joe was mission-critical for our 2025 program," said Scott Pantel, CEO of LSI and Publisher of The Lens. "His career embodies the audacity and patient-first ethos we work to amplify. From Masimo's garage-born breakthroughs to Willow's prevention-focused playbook, Joe speaks to the heart of why this community convenes with us each spring." About The Lens Magazine Built by medtech insiders, for medtech executives, The Lens magazine is LSI's most refined industry coverage. Each monthly edition of The Lens features data-driven industry insights, in-depth executive profiles, and exclusive market analyses for global medtech leaders. Individual and team-wide subscriptions can be started at About LSI USA With a vision to create a new platform for connection and exposure — one that matched the pace, ambition, and quality of the executives driving medtech forward — LSI launched its first Emerging Medtech Summit in Dana Point, California in 2020. To date, LSI has hosted nine summits and welcomed more than 10,000 global executives from 54 countries. Attendees of LSI USA include C-Suite executives, strategic acquirers, capital providers, and policy leaders, from companies including 3M, Abbott, Allergan, Boston Scientific, Cardinal Health, Cleveland Clinic, Danaher, Deloitte, Edwards Lifesciences, GE Healthcare, Goldman Sachs, Hologic, Integra Lifesciences, Intuitive Surgical, Johnson & Johnson, JP Morgan, Mayo Clinic, Medtronic, Olympus, Siemens Healthineers, Smith & Nephew, Stryker, Terumo, Varian, and Zimmer Biomet. On March 16 – 20th 2026, LSI USA will return to the Waldorf Astoria Monarch Beach Resort in Dana Point, California. The Summit will feature four days of curated 1:1 meetings, panel and keynote talks, emerging company pitches and technology showcases. Register today at View source version on Contacts Media Contact Henry Peck, Chief Business Officerinfo@ 714-847-3540 Sign in to access your portfolio
Business Wire
05-05-2025
- Business
- Business Wire
The Lens Magazine Features Joe Kiani, Willow Laboratories Founder and Nutu Visionary, on Cover of Latest Issue Following LSI USA ‘25 Keynote
DANA POINT, Calif.--(BUSINESS WIRE)-- The Lens, LSI's executive-focused medtech magazine, proudly unveils Volume 2, Edition 3, featuring Joe Kiani, Founder and Executive Chairman of Willow Laboratories and visionary of the digital-health platform Nutu, as its cover story. Kiani, a trailblazing figure in health technology, shares exclusive insights into the future of patient monitoring, the evolution of medical device innovation and the critical role of patient safety initiatives globally. In the powerful discussion, Joe Kiani and the Audacity to Care: Reflections on Principle, Persistence, and Patient-Centered Innovation, Kiani shares the journey that began in a garage with a $40,000 loan and now shapes standards of care for hundreds of millions of patients worldwide. The profile charts his early pulse-oximetry breakthroughs at Masimo, his bold crusades against entrenched purchasing monopolies, and his latest mission to out-innovate diabetes through Willow Labs. He also opens up about founding the Patient Safety Movement Foundation and leading the charge toward eliminating preventable deaths in hospitals worldwide. 'We have a real responsibility and an opportunity to change people's lives for the better,' said Kiani. 'And it's not easy. But it's everything.' The in-depth feature also spotlights Nutu, Willow Labs' science-backed 'nudge' platform that empowers people with pre-diabetes to reverse disease progression through personalized, data-driven coaching. Kiani also shares his vision for the future, where technology and compassion merge to save lives. 'Sometimes the unintended consequences of what we do are greater than the consequences we planned. But if you keep your compass set on doing what's right for patients, good things can happen,' Kiani adds. "Joe Kiani embodies the spirit of innovation and impact that The Lens seeks to celebrate," said Scott Pantel, CEO of LSI. "His unwavering commitment to advancing healthcare outcomes makes him one of the most influential voices in our industry today." The latest issue of The Lens is available for subscribers in print and digitally. To become a subscriber and access the full cover story, visit Marquee Keynote at LSI USA '25 Building on the cover collaboration, LSI was honored to host Joe Kiani to deliver the opening keynote address at LSI USA '25, March 17-21, 2025, at the Waldorf Astoria Monarch Beach Resort in Dana Point, California. Kiani's appearance opened a week that drew more than 1,600 executives, 450 emerging startup companies, 350 active investors from venture capital, private equity, family offices, accelerators, and angel groups, and key decision makers from multinational corporations including Medtronic, Boston Scientific, Intuitive and more. Kiani's remarks underscored the summit's 2025 theme of preventive and personalized care. 'Landing Joe was mission-critical for our 2025 program,' said Scott Pantel, CEO of LSI and Publisher of The Lens. 'His career embodies the audacity and patient-first ethos we work to amplify. From Masimo's garage-born breakthroughs to Willow's prevention-focused playbook, Joe speaks to the heart of why this community convenes with us each spring.' About The Lens Magazine Built by medtech insiders, for medtech executives, The Lens magazine is LSI's most refined industry coverage. Each monthly edition of The Lens features data-driven industry insights, in-depth executive profiles, and exclusive market analyses for global medtech leaders. Individual and team-wide subscriptions can be started at About LSI USA With a vision to create a new platform for connection and exposure — one that matched the pace, ambition, and quality of the executives driving medtech forward — LSI launched its first Emerging Medtech Summit in Dana Point, California in 2020. To date, LSI has hosted nine summits and welcomed more than 10,000 global executives from 54 countries. Attendees of LSI USA include C-Suite executives, strategic acquirers, capital providers, and policy leaders, from companies including 3M, Abbott, Allergan, Boston Scientific, Cardinal Health, Cleveland Clinic, Danaher, Deloitte, Edwards Lifesciences, GE Healthcare, Goldman Sachs, Hologic, Integra Lifesciences, Intuitive Surgical, Johnson & Johnson, JP Morgan, Mayo Clinic, Medtronic, Olympus, Siemens Healthineers, Smith & Nephew, Stryker, Terumo, Varian, and Zimmer Biomet. On March 16 – 20 th 2026, LSI USA will return to the Waldorf Astoria Monarch Beach Resort in Dana Point, California. The Summit will feature four days of curated 1:1 meetings, panel and keynote talks, emerging company pitches and technology showcases. Register today at
Yahoo
17-03-2025
- Business
- Yahoo
Vektor Medical Strengthens Leadership Team to Accelerate Commercial Growth and Market Expansion
Corporate Update to be Presented at LSI USA SAN DIEGO, March 17, 2025--(BUSINESS WIRE)--Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced key leadership appointments to support commercial expansion and market entry initiatives. Michael Andersen has joined the company as Vice President, Sales, and Mihir Naik has been promoted to Vice President, Quality Assurance and Regulatory Affairs. These key moves position Vektor for rapid growth following its recently oversubscribed $25M Series A funding round. "The expansion of our leadership team comes at a pivotal moment as we advance commercialization and prepare to enter new markets; we must have the right leadership in place to execute our strategy," said Rob Krummen, CEO of Vektor Medical. "Mike brings the expertise and experience to continue to expand vMap adoption among electrophysiologists, while Mihir's leadership ensures we maintain the highest regulatory and quality standards as we grow. Their leadership is instrumental as we work to deliver on our mission to transform arrhythmia care. I look forward to sharing more about our progress and vision during my presentation at LSI this week." Michael Andersen, VP, Sales Michael Andersen brings more than 20 years of commercial leadership experience in electrophysiology and medtech, with a strong track record of market development, sales execution, and strategic growth. Previously, he held senior roles at Hillrom, Abbott, and St. Jude Medical, where he successfully launched and expanded sales of advanced electrophysiology solutions. His expertise will be key in driving the adoption of vMap and accelerating revenue growth as Vektor expands its market presence. Mihir Naik, VP, Quality Assurance and Regulatory Affairs Mihir Naik has been promoted to Vice President, Quality Assurance and Regulatory Affairs, reinforcing Vektor's unwavering commitment to patient safety, quality and regulatory excellence. Since joining the company, Mihir has played a key role in ensuring FDA compliance, a robust quality and compliance framework that supports commercial success while meeting global industry standards. Corporate Update at LSI USA CEO Rob Krummen will present a corporate update at LSI USA in Dana Point, California, on March 19 at 1:45 PM PST. The presentation will cover Vektor Medical's strengthened leadership, commercial momentum, and commitment to innovation - fueled by the $25M Series A funding round, led by TVM Biosciences and Solas Bioventures. It will also provide insights into our future strategies and plans for vMap adoption and market expansion. For more information on Vektor Medical and vMap, visit and connect on LinkedIn and X. About Vektor Medical Headquartered in San Diego, Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-powered, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. For more information about vMap and Vektor Medical, please visit View source version on Contacts Media Contact Stacey HolifieldLevitate(617) 233-3873vektor@ Sign in to access your portfolio
Associated Press
17-03-2025
- Business
- Associated Press
Vektor Medical Strengthens Leadership Team to Accelerate Commercial Growth and Market Expansion
Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced key leadership appointments to support commercial expansion and market entry initiatives. Michael Andersen has joined the company as Vice President, Sales, and Mihir Naik has been promoted to Vice President, Quality Assurance and Regulatory Affairs. These key moves position Vektor for rapid growth following its recently oversubscribed $25M Series A funding round. 'The expansion of our leadership team comes at a pivotal moment as we advance commercialization and prepare to enter new markets; we must have the right leadership in place to execute our strategy,' said Rob Krummen, CEO of Vektor Medical. 'Mike brings the expertise and experience to continue to expand vMap adoption among electrophysiologists, while Mihir's leadership ensures we maintain the highest regulatory and quality standards as we grow. Their leadership is instrumental as we work to deliver on our mission to transform arrhythmia care. I look forward to sharing more about our progress and vision during my presentation at LSI this week.' Michael Andersen, VP, Sales Michael Andersen brings more than 20 years of commercial leadership experience in electrophysiology and medtech, with a strong track record of market development, sales execution, and strategic growth. Previously, he held senior roles at Hillrom, Abbott, and St. Jude Medical, where he successfully launched and expanded sales of advanced electrophysiology solutions. His expertise will be key in driving the adoption of vMap and accelerating revenue growth as Vektor expands its market presence. Mihir Naik, VP, Quality Assurance and Regulatory Affairs Mihir Naik has been promoted to Vice President, Quality Assurance and Regulatory Affairs, reinforcing Vektor's unwavering commitment to patient safety, quality and regulatory excellence. Since joining the company, Mihir has played a key role in ensuring FDA compliance, a robust quality and compliance framework that supports commercial success while meeting global industry standards. Corporate Update at LSI USA CEO Rob Krummen will present a corporate update at LSI USA in Dana Point, California, on March 19 at 1:45 PM PST. The presentation will cover Vektor Medical's strengthened leadership, commercial momentum, and commitment to innovation - fueled by the $25M Series A funding round, led by TVM Biosciences and Solas Bioventures. It will also provide insights into our future strategies and plans for vMap adoption and market expansion. For more information on Vektor Medical and vMap, visit and connect on LinkedIn and X. About Vektor Medical Headquartered in San Diego, Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-powered, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. For more information about vMap and Vektor Medical, please visit Stacey Holifield Levitate (617) 233-3873 SOURCE: Vektor Medical Copyright Business Wire 2025. PUB: 03/17/2025 10:15 AM/DISC: 03/17/2025 10:17 AM
